Hypoxia and/or
ischemia are implicated in
neurodegenerative disorders. In these diseases,
hypoxia/
ischemia may induce oxidative stress, including production of
reactive oxygen species (ROS), which result in a decrease in
glutamate transporter expression.
Hydrogen sulfide (H2S), as the third
gasotransmitter, has
neuroprotective effects and potent
antioxidant properties. In the present study, we investigated the role of
glutamate transporter-1 (GLT-1) in the protection of H2S against chemical
hypoxia-induced injury in PC12 cells. We found that
cobalt chloride (CoCl2), a chemical
hypoxia agent, reduced the expression of GLT-1 in a time-dependent manner. Pretreatment with
NaHS (a donor of H2S) reversed the CoCl2-induced downregulation of GLT-1 expression. Pretreatment with DHK (a selective inhibitor of GLT-1) for 30 min prior to
NaHS preconditioning significantly inhibited the cytoprotection of H2S against CoCl2-induced
injuries, leading to an increase in cytotoxicity and apoptosis as well as to a loss of mitochondrial membrane potential (
MMP). In addition, we found that similar to the effect of
NaHS, pretreatment with NAC (a ROS scavenger) or
U0126 (a MEK1/2 inhibitor) blocked the downregulation of GLT-1 expression induced by CoCl2. Collectively, we demonstrated for the first time that ROS and
extracellular signal-regulated kinase 1/2 (ERK1/2)-mediated reduction of GLT-1 expression may be involved in chemical
hypoxia-induced neural injury and that H2S attenuates this injury partly by upregulating GLT-1 expression in PC12 cells.